Watchlist Price Alert

Eton Pharmaceuticals Inc. (ETON)

NASDAQ: ETON · Real-Time Price · USD

13.91

-0.26 (-1.83%)

At close: Jun 17, 2025, 3:18 PM

Eton Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-3.82M	-936K	-9.02M	-1.96M	-27.97M	-18.32M	-12.74M	-7.16M
Depreciation & Amortization	1.15M	901K	1.77M	462K	651K	447K	63K	13K
Stock-Based Compensation	3.17M	3.14M	4.22M	3.38M	2.58M	1.89M	1.85M	2.64M
Other Working Capital	n/a	5.46M	4.12M	-910K	-320K	-827K	-314K	84K
Other Non-Cash Items	1.18M	117K	127K	148K	1.39M	16K	2.58M	1.29M
Deferred Income Tax	n/a	n/a	n/a	-546K	n/a	n/a	n/a	n/a
Change in Working Capital	-698K	3.6M	7.72M	-6.21M	1.01M	-2.06M	99K	623K
Operating Cash Flow	969K	6.82M	4.82M	-4.72M	-22.35M	-18.03M	-8.14M	-4.72M
Capital Expenditures	-26K	-775K	-2.79M	-3.26M	-50K	-1.85M	-236K	-130K
Cash Acquisitions	-30M	n/a	n/a	700K	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-9.99M	n/a	-2.75M	-2.55M	n/a	-750K	n/a	n/a
Investing Cash Flow	-40.01M	-775K	-2.79M	-2.56M	-50K	-1.85M	-236K	-130K
Debt Repayment	24.15M	-1.16M	-385K	-150K	2.48M	4.75M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	-1.05M	n/a
Other Financial Acitivies	248K	198K	251K	541K	367K	453K	205K	18M
Financial Cash Flow	32.59M	-957K	-134K	391K	31.63M	5.2M	21.96M	18M
Net Cash Flow	-6.45M	5.08M	1.9M	-6.89M	9.23M	-14.67M	13.58M	13.16M
Free Cash Flow	943K	6.04M	2.03M	-7.98M	-22.4M	-19.87M	-8.38M	-4.85M